Urolithin A for Mitochondrial Function

Research suggests that urolithin A (UA) supports mitochondrial function primarily by promoting mitophagy, the cellular process by which damaged or dysfunctional mitochondria are identified and cleared, with preclinical studies conducted in cell cultures and animal models reporting benefits across a wide range of tissues including muscle, heart, brain, joints, skin, and the blood and immune system. Studies indicate that these mitochondria-supporting effects appear to underlie UA's observed protective actions against age-related decline, inflammation, and tissue damage in laboratory settings, though the bulk of this evidence comes from in vitro and animal studies rather than human trials. The most direct human evidence comes from a randomized, double-blind, placebo-controlled trial in older adults, which produced mixed results: UA did not significantly improve the primary endpoints of walking distance or maximal ATP production in muscle, but did show meaningful improvements in muscle endurance and reductions in inflammatory biomarkers, suggesting a real but perhaps more modest effect than preclinical data might imply. Overall, the research base is promising but still early, with most mechanistic findings awaiting replication in well-powered human clinical trials before firm conclusions about the magnitude or breadth of UA's benefits for mitochondrial health in people can be drawn.